Ventricular tachycardia perfusion scintigraphy with pharmacologic stress

Ventricular tachycardia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Ventricular Tachycardia from other Disorders
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiography
Cardiac MRI
Other Diagnostic Tests
Treatment
Medical Therapy
Electrical Cardioversion
Ablation
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ventricular tachycardia perfusion scintigraphy with pharmacologic stress On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ventricular tachycardia perfusion scintigraphy with pharmacologic stress
CDC onVentricular tachycardia perfusion scintigraphy with pharmacologic stress
Ventricular tachycardia perfusion scintigraphy with pharmacologic stress in the news
Blogs on Ventricular tachycardia perfusion scintigraphy with pharmacologic stress
to Hospitals Treating Ventricular tachycardia perfusion scintigraphy with pharmacologic stress
Risk calculators and risk factors for Ventricular tachycardia perfusion scintigraphy with pharmacologic stress

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.